Sort
15,842 grants matching “pancreatic cancer”
Preclinical Development of ACXT-3102 for the Treatment of Pancreatic Adenocarcinoma (PDAC)
$1,019,186Bradley T. Keller · Accuronix Therapeutics, Inc. · R42 · FY2022 · CA
EndoPulse System for Endoscopic Ultrasound-Guided Therapy of Pancreatic Carcinoma
$1,019,109Richard Lee Nuccitelli · Bioelectromed Corporation · R44 · FY2012 · CA
Comprehensive validation and commercial readiness of SpliceIO, a software platform for neoantigen discovery using RNA-seq data
$1,018,170Martin Akerman · Envisagenics, Inc. · R44 · FY2022 · CA
Nanotechnology for Multiplexed and Intraoperative Cancer Detection
$1,017,561Shuming Nie · Emory University · RC2 · FY2010 · CA
Commercializing CivaSheet for Pancreatic Cancer Patients
$1,017,318Kristy Perez · Civatech Oncology, Inc. · R44 · FY2025 · CA
Interrogating the Evolutionary Dynamics of Cancer for Clinical Benefit and Actionability
$1,017,044Christine A Iacobuzio-Donahue · Sloan-Kettering Inst Can Research · R35 · FY2023 · CA
Interrogating the Evolutionary Dynamics of Cancer for Clinical Benefit and Actionability
$1,017,043Christine A Iacobuzio-Donahue · Sloan-Kettering Inst Can Research · R35 · FY2022 · CA
Identifying Metabolic Dependencies of Pancreatic Cancers
$1,017,000Alec Kimmelman · New York University School Of Medicine · R35 · FY2021 · CA
Intracellular In vivo Imaging
$1,016,705Peter L. Choyke · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA
Spatial functional genomics to identify regulators of the tumor microenvironment and cancer immunity
$1,015,368Brian D Brown · Icahn School Of Medicine At Mount Sinai · U01 · FY2025 · CA
SPORE in Pancreatic Cancer
$1,015,068University Of Alabama At Birmingham · P20 · FY2005 · CA
Preclinical Development of ACXT-3102 for the Treatment of Pancreatic Adenocarcinoma (PDAC)
$1,014,729Bradley T. Keller · Accuronix Therapeutics, Inc. · R42 · FY2021 · CA
Circulating Biomarkers and Imaging for Early Detection of Pancreatic Cancer
$1,013,807Subrata Sen · University Of Tx Md Anderson Can Ctr · U01 · FY2022 · CA
Molecular signatures for liver cancer diagnosis and treatment stratification
$1,013,528Xin Wang · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA
NIA Confocal Imaging Facility
$1,013,467Fred Indig · National Institute On Aging · ZIC · FY2018 · AG
SPORE in Gastrointestinal Cancer
$1,013,333Michael A Hollingsworth · University Of Nebraska Medical Center · P50 · FY2011 · CA
An integrated computational and functional genomics discovery engine for preclini
$1,013,016Christopher J Kemp · Fred Hutchinson Cancer Research Center · U01 · FY2014 · CA
Overhauser Enhanced Magnetic Resonance Imaging (OMRI)
$1,012,304Murali Cherukuri · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA
Interrogating the Evolutionary Dynamics of Cancer for Clinical Benefit and Actionability
$1,012,275Christine A Iacobuzio-Donahue · Sloan-Kettering Inst Can Research · R35 · FY2018 · CA
Development of TIMP-2 derivatives or strategies as biologic therapies for cancer
$1,011,465William Stetler-Stevenson · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
Phase I Clinical Testing of a First-in-Class Therapy against Metastatic Cancer
$1,011,207Zdravka O. Medarova · Transcode Therapeutics, Inc. · R44 · FY2024 · CA
PASSCODE (Pancreatic Adenocarcinoma Stromal Reprograming ConSortium COordination, Data Management and Education)
$1,010,953Anirban Maitra · New York University School Of Medicine · U24 · FY2025 · CA
An integrated computational and functional genomics discovery engine for preclini
$1,009,007Christopher J Kemp · Fred Hutchinson Cancer Research Center · U01 · FY2016 · CA
FrostBite - A Unique Catheter for Endoscopic Cryoablation
$1,008,442J M Baust · Cell Preservation Services, Inc. · R44 · FY2017 · CA
Robust Predictor of Breast Cancer Risk
$1,008,203Harry Ostrer · Morgan And Mendel Genomics, Inc. · R42 · FY2021 · CA